Paper Details

  1. Home
  2. Paper Details

Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence.

Author: FalagasMatthew E, MantaKaterina G, NtzioraFotinie, VardakasKonstantinos Z

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Linezolid is an antibiotic effective against certain bacteria (Gram-positive cocci) that causes infections like pneumonia, skin infections, and potentially bloodstream infections. While it's mainly used for these conditions, it's sometimes used for treating heart valve infections (endocarditis) caused by bacteria resistant to other antibiotics.
Paper Details　
Original Abstract of the Article :
Linezolid is a bacteriostatic oxazolidinone antibiotic that has been proven to be effective for the treatment of patients with pneumonia, skin and soft tissue infections, and possibly bacteraemia, due to Gram-positive cocci. However, the drug is sometimes used for the treatment of patients with endo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/jac/dkl219

データ提供：米国国立医学図書館（NLM）

Linezolid: A Potential Treatment for Endocarditis

This research journeys into the world of infectious diseases, a realm as complex and challenging as the ever-shifting sands of the Sahara. The study examines the potential of linezolid, a novel antibiotic, in treating endocarditis, a serious infection of the heart valves. The authors, like skilled desert navigators, systematically reviewed existing evidence, highlighting the drug's potential for treating Gram-positive cocci infections, including those resistant to other antibiotics. The research offers a potential solution to a pressing medical concern, providing hope for patients facing a difficult diagnosis.

Linezolid: A Potential Hope for Endocarditis Treatment

Linezolid has demonstrated effectiveness in treating various infections caused by Gram-positive cocci, including pneumonia, skin and soft tissue infections, and potentially even bacteremia. This research suggests that linezolid could offer a promising treatment option for endocarditis caused by bacteria resistant to other antibiotics. It's like finding a hidden oasis in the vast desert of infectious diseases, offering a source of relief and hope for patients struggling with this serious condition.

Navigating the Challenges of Endocarditis

This research underscores the importance of finding new and effective treatment options for endocarditis, especially those caused by bacteria resistant to conventional antibiotics. It's crucial to remember that any medication should be used under the guidance of a healthcare professional. Like a skilled desert guide, a doctor can help determine the best treatment approach for each patient, ensuring a safe and successful recovery.

Dr. Camel's Conclusion

This research offers a potential new weapon in the battle against endocarditis, a serious heart infection. Linezolid, a novel antibiotic, shows promise in treating infections caused by Gram-positive cocci, including those resistant to other antibiotics. It's like discovering a new and powerful weapon in the vast desert of infectious diseases, offering hope for patients facing this challenging condition.

Date :
  1. Date Completed 2006-12-11
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

16735427

DOI: Digital Object Identifier

10.1093/jac/dkl219

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.